Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA grants rare pediatric disease and fast track designations to Audentes' AT-132

Sep. 28, 2017

Acer Therapeutics reports results from pivotal study of Edsivo in vascular Ehlers-Danlos syndrome

Sep. 27, 2017

Pluristem planning phase III study of PLX-PAD cells for muscle recovery after arthroplasty

Sep. 27, 2017

Medivir reports promising topline data on MIV-711 in knee osteoarthritis

Sep. 27, 2017

Janssen Biotech receives complete response letter for sirukumab BLA

Sep. 26, 2017

ImmuPharma offers update on Lupuzor program

Sep. 26, 2017

NIH grant to support development of Cel-Sci's rheumatoid arthritis vaccine

Sep. 20, 2017

Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo

Sep. 18, 2017

Phase III trial of upadacitinib in rheumatoid arthritis meets all endpoints

Sep. 12, 2017

Daiichi Sankyo and Sanford Burnham Prebys begin clinical trial of DS-1211

Sep. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.